EPIC Program Annual Data Tables 2006-2007: Table VII

Table VII
Ten Most Frequently Purchased Types of Drugs
by Therapeutic Classification^*

Therapeutic Class**	Number of Claims	Percent of Claims	EPIC Payments	Number of Participants
Total***	5,272,023	46.90%	$336,258,835
BETA-ADRENERGIC BLOCKING AGENT	1,205,499	10.73%	$38,890,866	164,503
HMG-COA REDUCTASE INHIBITORS	729,540	6.49%	$75,486,343	154,665
DIHYDROPYRIDINES	574,510	5.11%	$36,045,499	77,961
ANGIOTENSIN-CONVERTING ENZYME	536,630	4.78%	$14,533,035	105,144
PROTON-PUMP INHIBITORS	434,323	3.86%	$65,380,312	100,689
ANTIDEPRESSANTS	399,759	3.56%	$22,355,978	72,297
ANGIOTENSIN II RECEPTOR ANTAGO	387,127	3.44%	$26,305,827	79,255
PLATELET-AGGREGATION INHIBITOR	339,347	3.02%	$42,192,824	40,749
OPIATE AGONISTS	336,804	2.99%	$11,433,522	89,201
THYROID AGENTS	328,484	2.92%	$3,634,629	62,932

^* Table VII provides the percent of adjudicated claims for the program year (October 1, 2006 through September 30, 2007) as they fall into particular categories of Therapeutic Class.

^** American Hospital Formulary Service® (AHFS) Pharmacologic-Therapeutic Classification.

^*** This report contains the top ten drug classes; additional drug classes comprise the remainder of claims up to 100.00%.